Twist Bioscience (TWST) News Today $41.31 -3.77 (-8.36%) Closing price 04:00 PM EasternExtended Trading$41.41 +0.10 (+0.24%) As of 07:58 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 Time Period State of New Jersey Common Pension Fund D Boosts Holdings in Twist Bioscience Co. (NASDAQ:TWST)State of New Jersey Common Pension Fund D grew its stake in Twist Bioscience Co. (NASDAQ:TWST - Free Report) by 12.6% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 50,803 shares of the company's stock aFebruary 21 at 3:53 AM | marketbeat.comBaillie Gifford & Co. Sells 56,802 Shares of Twist Bioscience Co. (NASDAQ:TWST)Baillie Gifford & Co. lowered its stake in Twist Bioscience Co. (NASDAQ:TWST - Free Report) by 6.8% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 777,537 shares of the company's stock after selling 56,802 shareFebruary 18 at 4:49 AM | marketbeat.comInsider Selling: Twist Bioscience Co. (NASDAQ:TWST) Director Sells 2,940 Shares of StockFebruary 12, 2025 | insidertrades.comTwist Bioscience director Robert Chess sells shares totaling $156,216February 11, 2025 | msn.comTwist Bioscience approves stock increase, officer exculpationFebruary 11, 2025 | msn.comTwist Bioscience Co. (NASDAQ:TWST) Director Robert Chess Sells 2,940 SharesTwist Bioscience Co. (NASDAQ:TWST - Get Free Report) Director Robert Chess sold 2,940 shares of the company's stock in a transaction dated Friday, February 7th. The shares were sold at an average price of $53.13, for a total transaction of $156,202.20. Following the transaction, the director now directly owns 18,173 shares of the company's stock, valued at approximately $965,531.49. This represents a 13.93 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link.February 11, 2025 | marketbeat.comCathie Wood’s ARK Investment bought 268K shares of Twist Bioscience todayFebruary 11, 2025 | markets.businessinsider.comTwist Bioscience (NASDAQ:TWST) Shares Down 5.8% - Should You Sell?Twist Bioscience (NASDAQ:TWST) Shares Down 5.8% - Here's What HappenedFebruary 10, 2025 | marketbeat.comSumitomo Mitsui Trust Group Inc. Sells 248,702 Shares of Twist Bioscience Co. (NASDAQ:TWST)Sumitomo Mitsui Trust Group Inc. lowered its position in shares of Twist Bioscience Co. (NASDAQ:TWST - Free Report) by 8.7% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 2,612,964 shares of the company's stock after seFebruary 9, 2025 | marketbeat.comEarnings Update: Twist Bioscience Corporation (NASDAQ:TWST) Just Reported Its First-Quarter Results And Analysts Are Updating Their ForecastsFebruary 8, 2025 | uk.finance.yahoo.comTwist Bioscience Corporation (TWST): Among Cathie Wood’s Top Stock Picks for 2025February 7, 2025 | msn.comLeerink Partnrs Analysts Boost Earnings Estimates for TWSTTwist Bioscience Co. (NASDAQ:TWST - Free Report) - Stock analysts at Leerink Partnrs boosted their Q2 2025 earnings per share estimates for Twist Bioscience in a research report issued to clients and investors on Monday, February 3rd. Leerink Partnrs analyst P. Souda now anticipates that the compFebruary 6, 2025 | marketbeat.comWilliam Blair Analysts Increase Earnings Estimates for TWSTTwist Bioscience Co. (NASDAQ:TWST - Free Report) - William Blair increased their Q2 2025 earnings estimates for shares of Twist Bioscience in a report released on Tuesday, February 4th. William Blair analyst M. Larew now anticipates that the company will post earnings of ($0.55) per share for theFebruary 6, 2025 | marketbeat.comTwist Bioscience Co. (NASDAQ:TWST) Insider Dennis Cho Sells 806 SharesFebruary 6, 2025 | insidertrades.comTwist Bioscience: Valuation Is Weighing On The StockFebruary 6, 2025 | seekingalpha.comInsider Selling: Twist Bioscience Co. (NASDAQ:TWST) Insider Sells 806 Shares of StockTwist Bioscience Co. (NASDAQ:TWST - Get Free Report) insider Dennis Cho sold 806 shares of the company's stock in a transaction that occurred on Monday, February 3rd. The shares were sold at an average price of $49.35, for a total transaction of $39,776.10. Following the completion of the transaction, the insider now owns 112,221 shares of the company's stock, valued at approximately $5,538,106.35. This trade represents a 0.71 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink.February 5, 2025 | marketbeat.comPaula Green Sells 1,259 Shares of Twist Bioscience Co. (NASDAQ:TWST) StockTwist Bioscience Co. (NASDAQ:TWST - Get Free Report) SVP Paula Green sold 1,259 shares of the stock in a transaction dated Monday, February 3rd. The stock was sold at an average price of $49.35, for a total value of $62,131.65. Following the sale, the senior vice president now owns 132,014 shares of the company's stock, valued at approximately $6,514,890.90. The trade was a 0.94 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink.February 5, 2025 | marketbeat.comTwist Bioscience Co. (NASDAQ:TWST) COO Sells $140,400.75 in StockTwist Bioscience Co. (NASDAQ:TWST - Get Free Report) COO Patrick John Finn sold 2,845 shares of Twist Bioscience stock in a transaction dated Monday, February 3rd. The stock was sold at an average price of $49.35, for a total transaction of $140,400.75. Following the completion of the transaction, the chief operating officer now directly owns 269,199 shares of the company's stock, valued at $13,284,970.65. This trade represents a 1.05 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through the SEC website.February 5, 2025 | marketbeat.comTwist Bioscience Co. (NASDAQ:TWST) CEO Sells $256,620.00 in StockTwist Bioscience Co. (NASDAQ:TWST - Get Free Report) CEO Emily M. Leproust sold 5,200 shares of the company's stock in a transaction on Monday, February 3rd. The shares were sold at an average price of $49.35, for a total value of $256,620.00. Following the completion of the sale, the chief executive officer now directly owns 667,318 shares in the company, valued at $32,932,143.30. This trade represents a 0.77 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink.February 5, 2025 | marketbeat.comWhat is William Blair's Forecast for TWST Q2 Earnings?Twist Bioscience Co. (NASDAQ:TWST - Free Report) - Equities research analysts at William Blair issued their Q2 2026 earnings per share estimates for Twist Bioscience in a note issued to investors on Tuesday, February 4th. William Blair analyst M. Larew expects that the company will post earningsFebruary 5, 2025 | marketbeat.comJennison Associates LLC Buys 302,884 Shares of Twist Bioscience Co. (NASDAQ:TWST)Jennison Associates LLC grew its stake in Twist Bioscience Co. (NASDAQ:TWST - Free Report) by 80.2% during the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 680,778 shares of the company's stock after puFebruary 5, 2025 | marketbeat.comTwist Bioscience (NASDAQ:TWST) Shares Down 3.7% - Time to Sell?Twist Bioscience (NASDAQ:TWST) Shares Down 3.7% - Here's What HappenedFebruary 4, 2025 | marketbeat.comTwist Bioscience's SWOT analysis: stock outlook amid operational gainsFebruary 4, 2025 | msn.comTwist Bioscience price target raised to $62 from $54 at ScotiabankFebruary 4, 2025 | markets.businessinsider.comTwist Bioscience (TWST) Receives a Sell from J.P. MorganFebruary 4, 2025 | markets.businessinsider.comTwist Bioscience Corporation (NASDAQ:TWST) Q1 2025 Earnings Call TranscriptFebruary 4, 2025 | msn.comTwist Bioscience (NASDAQ:TWST) Price Target Raised to $40.00 at JPMorgan Chase & Co.JPMorgan Chase & Co. upped their target price on Twist Bioscience from $35.00 to $40.00 and gave the company an "underweight" rating in a research report on Tuesday.February 4, 2025 | marketbeat.comTwist Bioscience (NASDAQ:TWST) Stock Price Expected to Rise, Scotiabank Analyst SaysScotiabank lifted their price target on shares of Twist Bioscience from $54.00 to $62.00 and gave the company a "sector outperform" rating in a report on Tuesday.February 4, 2025 | marketbeat.comTwist Bioscience (NASDAQ:TWST) Stock Price Expected to Rise, Robert W. Baird Analyst SaysRobert W. Baird raised their price target on Twist Bioscience from $48.00 to $54.00 and gave the stock an "outperform" rating in a report on Tuesday.February 4, 2025 | marketbeat.comTwist Bioscience raises 2025 revenue guidance to $372M-$379M amid strong SynBio and NGS growthFebruary 3, 2025 | msn.comTwist Bioscience price target raised to $58 from $52 at BarclaysFebruary 3, 2025 | markets.businessinsider.comTwist Bioscience (NASDAQ:TWST) Shares Gap Down - What's Next?Twist Bioscience (NASDAQ:TWST) Shares Gap Down - What's Next?February 3, 2025 | marketbeat.comTwist Bioscience (NASDAQ:TWST) Posts Earnings Results, Beats Expectations By $0.09 EPSTwist Bioscience (NASDAQ:TWST - Get Free Report) issued its earnings results on Monday. The company reported ($0.53) EPS for the quarter, topping analysts' consensus estimates of ($0.62) by $0.09. Twist Bioscience had a negative net margin of 66.69% and a negative return on equity of 32.27%.February 3, 2025 | marketbeat.comTwist Bioscience Corporation 2025 Q1 - Results - Earnings Call PresentationFebruary 3, 2025 | seekingalpha.comTwist Bioscience Announces Fiscal 2025 First Quarter Financial ResultsFebruary 3, 2025 | businesswire.comTwist Bioscience (TWST) Receives a Buy from BarclaysFebruary 3, 2025 | markets.businessinsider.comTwist Bioscience Co. (NASDAQ:TWST) Given Consensus Recommendation of "Moderate Buy" by BrokeragesTwist Bioscience Co. (NASDAQ:TWST - Get Free Report) has been assigned an average recommendation of "Moderate Buy" from the ten ratings firms that are presently covering the company, MarketBeat.com reports. One research analyst has rated the stock with a sell rating, one has assigned a hold ratiFebruary 2, 2025 | marketbeat.comTwist Bioscience Corp (TWST) Q1 2025 Earnings Report Preview: What to Look ForJanuary 31, 2025 | uk.finance.yahoo.comTwist Bioscience Co. (NASDAQ:TWST) Shares Sold by Exchange Traded Concepts LLCExchange Traded Concepts LLC reduced its holdings in shares of Twist Bioscience Co. (NASDAQ:TWST - Free Report) by 31.3% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 13,830 shares of the company's stJanuary 30, 2025 | marketbeat.comPatrick John Finn Sells 2,422 Shares of Twist Bioscience Co. (NASDAQ:TWST) StockJanuary 28, 2025 | insidertrades.comTwist Bioscience Co. (NASDAQ:TWST) COO Sells $121,511.74 in StockTwist Bioscience Co. (NASDAQ:TWST - Get Free Report) COO Patrick John Finn sold 2,422 shares of the stock in a transaction on Thursday, January 23rd. The stock was sold at an average price of $50.17, for a total value of $121,511.74. Following the transaction, the chief operating officer now directly owns 272,044 shares in the company, valued at approximately $13,648,447.48. This represents a 0.88 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website.January 27, 2025 | marketbeat.comTwist Bioscience (NASDAQ:TWST) Stock Price Down 4.5% - What's Next?Twist Bioscience (NASDAQ:TWST) Trading Down 4.5% - What's Next?January 23, 2025 | marketbeat.comGene Synthesis Market Size to Surpass USD 9.54 Billion by 2033 | Straits ResearchJanuary 23, 2025 | globenewswire.comAvanza Fonder AB Takes $1.06 Million Position in Twist Bioscience Co. (NASDAQ:TWST)Avanza Fonder AB purchased a new position in Twist Bioscience Co. (NASDAQ:TWST - Free Report) during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm purchased 22,791 shares of the company's stock, valued at approximatelyJanuary 20, 2025 | marketbeat.comTwist Bioscience (NASDAQ:TWST) Shares Up 9.5% - Here's WhyTwist Bioscience (NASDAQ:TWST) Trading 9.5% Higher - What's Next?January 15, 2025 | marketbeat.comInsider Selling: Twist Bioscience Co. (NASDAQ:TWST) CFO Sells 5,886 Shares of StockTwist Bioscience Co. (NASDAQ:TWST - Get Free Report) CFO Adam Laponis sold 5,886 shares of the stock in a transaction dated Friday, January 10th. The shares were sold at an average price of $43.26, for a total transaction of $254,628.36. Following the completion of the sale, the chief financial officer now owns 110,096 shares of the company's stock, valued at approximately $4,762,752.96. The trade was a 5.07 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink.January 14, 2025 | marketbeat.comTwist Bioscience Co. (NASDAQ:TWST) Director Sells $250,000.00 in StockJanuary 11, 2025 | insidertrades.comRobert Chess Sells 5,000 Shares of Twist Bioscience Co. (NASDAQ:TWST) StockTwist Bioscience Co. (NASDAQ:TWST - Get Free Report) Director Robert Chess sold 5,000 shares of Twist Bioscience stock in a transaction on Tuesday, January 7th. The shares were sold at an average price of $50.00, for a total value of $250,000.00. Following the completion of the sale, the director now owns 16,641 shares in the company, valued at $832,050. This represents a 23.10 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website.January 10, 2025 | marketbeat.comPatrick John Finn Sells 229 Shares of Twist Bioscience Co. (NASDAQ:TWST) StockJanuary 8, 2025 | insidertrades.comTwist Bioscience Co. (NASDAQ:TWST) Given Average Recommendation of "Moderate Buy" by BrokeragesShares of Twist Bioscience Co. (NASDAQ:TWST - Get Free Report) have earned a consensus recommendation of "Moderate Buy" from the ten analysts that are currently covering the company, Marketbeat.com reports. One equities research analyst has rated the stock with a sell rating, one has issued a hoJanuary 8, 2025 | marketbeat.com Get Twist Bioscience News Delivered to You Automatically Sign up to receive the latest news and ratings for TWST and its competitors with MarketBeat's FREE daily newsletter. Email Address TWST Media Mentions By Week TWST Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. TWST News Sentiment▼1.650.60▲Average Medical News Sentiment TWST News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. TWST Articles This Week▼26▲TWST Articles Average Week Get Twist Bioscience News Delivered to You Automatically Sign up to receive the latest news and ratings for TWST and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Dr. Reddy's Laboratories News Vaxcyte News Sarepta Therapeutics News Qiagen News Ascendis Pharma A/S News Roivant Sciences News Revolution Medicines News Legend Biotech News BridgeBio Pharma News Axsome Therapeutics News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:TWST) was last updated on 2/21/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredElon “obliterates” Bill Gates?All 10 of the world's biggest money managers follow my work, and the Pentagon, the FBI and Harvard professors ...Altimetry | SponsoredNVDA Crash UpdateAn overseas AI rival sent shockwaves through the U.S. tech market last week... Leaving millions of investor...Chaikin Analytics | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | Sponsored My 2025 AI BlueprintI first recommended Bitcoin at $300 in 2013 … before it went up 33,645%. Now, I am revealing my 2025 AI Blu...Weiss Ratings | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredAmerica cannot power AIThere’s a fatal flaw at the heart of the AI revolution… With AI continuing to explode in popularity, tech c...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Twist Bioscience Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Twist Bioscience With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
